Page 313 - Read Online

Yang et al. Aggressive primary hepatic histiocytic sarcoma

receptor beta, and IGH genes may be seen and do approval by Institutional Review Board at Loma Linda
not exclude the diagnosis of HS. However, when HS University Medical Center.
is associated with lymphoma, identical clonal gene
rearrangements may be present. [13] REFERENCES

HS most commonly presents at an advanced clinical 1. Takahashi E, Nakamura S. Histiocytic sarcoma: an updated literature
stage, with poor response to chemotherapy and a high review based on the 2008 WHO classification. J Clin Exp Hematop
mortality rate. Although some patients may respond to 2013;53:1-8.
chemotherapy with or without radiotherapy, the majority 2. Hornick JL, Jaffe ES, Fletcher CD. Extranodal histi ocytic sarcoma:
of the patients die of progressive disease within two clinicopathologic analysis of 14 cases of a rare epithelioid malignancy.
years. Important prognostic factors include stage at 3. Am J Surg Pathol 2004;28:1133-44.
Mounajjed T, Chandan VS, Torbenson MS, editors. Surgical
presentation and tumor size. There are no accepted Pathology of Liver Tumors. Springer; 2015. p. 360-1.
staging or treatment guidelines due to the rarity of the 4. Llamas-Velasco M, Cannata J, Dominguez I, García-Noblejas
disease. [1] A, Aragües M, Fraga J, Arranz R. Coexistence of Langerhans cell
histiocytosis, Rosai-Dorfman disease and splenic lymphoma with
In conclusion, we present a rare case of primary hepatic fatal outcome after rapid development of histiocytic sarcoma of the
HS. The diagnosis is challenging, and requires a high liver. J Cutan Pathol 2012;39:1125-30.
index of suspicion. The diagnosis should be based 5. Rubtsova NA, Sidorov DV, Petrov LO, Zhukov NV, Vernyuk MA,
on a combination of compatible histomorphology and Pavlova OA. Diagnosis and treatment of primary sarcoma of the liver
positivity for histiocyte-specific markers, and also 6. (case review). Radiology 2014;1:43.
Chun HJ, Kee KH, Suh CH, Lim SC, Song HS. Primary malignant
requires exclusion of more common neoplasms by lymphoma of true histiocytic origin of the liver: histiocytic sarcoma,
extensive immunophenotypic studies. kupffer cell sarcoma: a case report with immunohistochemical and
ultrastructural studies. Korean J Pathol 1989;23:165-80.
Acknowledgments 7. Swerdllow SH, Campo E, Harris NL. WHO classification of tumours
The authors thank Mary Dennis and Maria Rabina of haematopoietic and lymphoid tissues. France: IARC Press; 2008. p.
(MHS PA) for assistance in specimen grossing, and 356-7.
Michael Mitchell for assistance in autopsy. 8. Mathé G, Gerard-Marchant R, Texier JL, Schlumberger JR,
Berumen L, Paintrand M. The two varieties of lymphoid tissue
“reticulosarcomas”, histiocytic and histioblastic types. Br J Cancer
Financial support and sponsorship 1970;24:687-95.
None. 9. Pakravan A, Bhatia R, Oshima K, Chen G, Fesler M, Prather C, Taylor
JR. Histiocytic sarcoma: the first reported case of primary esophageal
Conflicts of interest involvement. Am J Gastroenterol 2014;109:291-2.
There are no conflicts of interest. 10. Dalia S, Shao H, Sagatys E, Cualing H, Sokol L. Dendritic cell and
histiocytic neoplasms: biology, diagnosis, and treatment. Cancer
Control 2014;21:290-300.
Patient consent 11. Ohnishi K, Tanaka S, Oghiso Y, Takeya M. Immunohistochemical
The patient's parent(s) signed consents and documents detection of possible cellular origin of hepatic histiocytic sarcoma in
mice. J Clin Exp Hematop 2012;52:171-7.
are available for review upon request. 12. Lindberg MR. Diagnostic Pathology: Soft Tissue Tumors. Elsevier
Health Sciences; 2015. p. 310-1.
Ethics approval 13. Vasef MA, Auerbach A. Diagnostic Pathology: Molecular Oncology.
Case report is waived and does not require further Elsevier Health Sciences; 2016. p. 2-4.

304 Hepatoma Research ¦ Volume 2 ¦ November 07, 2016